CD44-targeted nanoparticles for co-delivery of docetaxel and an Akt inhibitor against colorectal cancer
Juan González‐Valdivieso, Reinaldo Vallejo, Soraya Rodríguez‐Rojo, Mercedes Santos, J. Schneider, Francisco Javier Arias, Alessandra Girotti
Topics & Concepts
NanocarriersColorectal cancerCancer researchDocetaxelDrug deliveryCD44Cancer cellIn vivoMedicineCancerPharmacologyDrugChemistryCellInternal medicineBiologyOrganic chemistryBiotechnologyBiochemistryNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsCellular Mechanics and Interactions